Текст книги "Клеймо ведьмы (СИ)"
Автор книги: Илия Телес
сообщить о нарушении
Текущая страница: 27 (всего у книги 123 страниц)
20. Bonica JJ: Management of myofascial pain syndromes in general practice. JAMA 164:732–738, 1957.
21. Boos R. Pannikulose und Pannikulitis. In: Fortbildungskurse fur Rheumatologie, Der Weichteilrheumatismus. Edited by Kaganas G, Mtiller W, Wagenhauser F, Vol. 1. S. Karger, Basel, 1971 (pp. 35–48).
22. Brand PW, Beach RB, Thompson DE: Relative tension and potential excursion of muscles in the forearm and hand. J Hand Surg 6:209–219, 1981.
23. Brin MF (Ed.): Spasticity: etiology, evaluation, management, and the role of Botulinum toxin type A. Muscle & Nerve Suppl. 6, 1997.
24. Brun A; Effect of procaine, caibocaine and xylocaine on cutaneous muscle in rabbits and mice. Acta Anaesthesiol Scand 3:59–73, 1959.
25. Burke GW, Jr., Fedison JR, Jones CR: Muscle degeneration produced by local anesthetics. Va Dent J 49:33–37, 1972.
26. Byl NN, McKenzie A, Halliday B, et al.: The effects of phonophoresis with corticosteroids: a controlled pilot study. J Orthop Sports Phys Ther 18(5):590–600 1993.
27. Cardenas DD, Stolov WC, Hardy MS: Muscle fiber number in immobilization atrophy. Arch Phys Med Rehabil 58:423–426, 1977.
28. Chan P: Finger Acupressure. Ballantine Books, New York, 1975.
29. Chemick WS: Local anesthetics. Chapter II. In: Drill’s Pharmacology in Medicine. Ed. 4. Edited by DiPalma JR. McGraw-Hill, New York, 1971 (pp. 190–193, 196–199).
30. Cheshire WP, Abashian SW, Mann JD: Botulinum toxin in the treatment of myofascial pain syndrome. Pain 59:65–69, 1994.
31. Chu J: Dry needling (intramuscular stimulation) in myofascial pain related to lum bosacral radiculopathy. Eur J Phys Med Rehabil 5(4): 106–121, 1995.
32. Chu J: Twitch-obtaining intramuscular stimulation: its effectiveness in the longterm treatment of myofascial pain related to lumbosacral radiculopathy. Arch Phys Med Rehabil 78:1024, 1997 (Abstr).
33. Clemente CD: Gray’s Anatomy of the Human Body, American Ed. 30. Lea & Febiger, Philadelphia, 1985.
34. Consumer Reports: Caffeine: how to consume less. Consumer Reports 597–599, October, 1981.
35. Copeman WS, Ackerman WL: «Fibrositis» of the back. QJ Med 13:37–51, 1944.
36. Covino BG: Local anesthesia (Parts One and Two). N Engl J Med 286:975–983, and 1035–1042, 1972.
37. Cyriax JH; Clinical applications of massage. Chapter 7. In: Manipulation, Traction and Massage. Ed. 2. Edited by Rogoff JB. Williams & Wilkins, Baltimore, 1980 (pp. 152–155).
38. Dalessio DJ: Wolff’s Headache and Other Head Pain. Ed. 3. Oxford University Press, New York, 1972 (p. 553).
39. D’Ambrogio KJ. Roth GB: Positional Release Therapy. Mosby, St. Louis, 1997.
40. Danneskiold-Samsde B, Christiansen E, Andersen RB: Regional muscle tension and pain («Fibrositis»). Scand J Rehab Med 15:17–20, 1983.
41. Danneskiold-Samsde B, Christiansen E, Andersen RB: Myofascial pain and the role of myoglobin. Scand J Rheumatol 15:174- 178, 1986.
42. Day BH, Govindasamy N, Patnaik R: Corticosteroid injections in the treatment of tennis elbow. Practitioner 220:459–462, 1978.
43. Eisler P: Die Muskein des Stammes. Gustav Fischer, Jena, 1912.
44. Fassbender HG: Non-articular rheumatism. Chapter 13. In: Pathology of Rheumatic Diseases. Springer-Verlag, New York, 1975 (pp. 303–314).
45. Fields HL (Editor). Core Curriculum for Professional Education cf the International Association for the Study of Pain. IASP Press, Seattle, 1995.
46. Fischer AA: New approaches in treatment of myofascial pain. In: Myofascial Pain-Update in Diagnosis and Treatment. Edited by Fischer AA. Phys Med Rehabil Clin North Am 8(1):153–169, 1997.
47. Fordyce WE: Behavioral Methods for Chronic Pain and Illness. С. V. Mosby, St. Louis, 1976.
48. Frank, E: Personal Communication, 1997.
49. Frost A: Diclofenac versus lidocaine as injection therapy in myofascial pain. Scand J Rheumatol 15:153–156, 1986.
50. Frost FA, Jessen B, Siggaard-Anderson J: A control, double-blind comparison of mepivacaine injection versus saline injection for myofascial pain. Lancet 1: 499–501, 1980.
51. Gardner DA: The use of ethyl chloride spray to relieve somatic pain. JAOA 49:525–528, 1950.
52. Geiwin RD, Shannon S, Hong CZ, et al: Interrater reliability in myofascial trigger point examination. Pain 69:65–73, 1997.
53. Glover JC, Yates HA: Strain and counterstrain, Chap. 58. In: Foundations for Osteopathic Medicine. Edited by Ward RC. Williams and Wilkins, Baltimore, 1997 (pp. 809–818).
54. Gold H, Travell J: Cornell conference on therapy: management of pain due to muscle spasm. NY State J Med 45:2085–2097, 1945 (pp. 2095–2096).
55. Good MG: Acroparaesthesia – an idiopathic myalgia of elbow. Edinburgh Med J 56:366–368, 1949.
56. Goodman LS, Gilman A: The Pharmacological Basis of Therapeutics. Ed. 4. Macmillan, London, 1970 (pp. 372–376, 382, 1662–1663).
57. Goodridge JP: Muscle energy technique procedures, Chapter 53. In: Foundations for Osteopathic Medicine. Edited by Ward RC. Williams and Wilkins, Baltimore, 1997 (pp. 691–696).
58. Gottlieb NL, Riskin WG: Complications of local corticosteroid injections. JAMA 243:1547–1548, 1980.
59. Greenman PE: Principles of Manual Medicine. Ed. 2. Williams & Wilkins, Baltimore, 1996 (pp. 39–49, 99-103, 539).
60. Gunn C. Chan: Personal Communication, 1995.
61. Gunn CC: The Gunn Approach to the Treatment of Chronic Pain-Intramuscular Stimulation for Myofascial Pain of Radiculopathic Origin. Churchill Livingstone, London, 1996.
62. Gunn CC, Milbrandt WE: Early and subtle signs in low-back sprain. Spine 3:267–281, 1978.
63. Hagbarth KE, Finer B: The plasticity of human withdrawal reflexes to noxious skin stimuli in lower limbs. Prog Brain Res 1:65–78, l%3.
64. Headley BJ: EMG and myofascial pain. Clinical Manage 10:43–46, 1990.
65. Hill AV: The mechanics of voluntary muscle. Lancet 2:947–951, 1951.
66. Hong CZ: Myofascial trigger point injection. Grit Rev Phys Med Rehabil 5:203–217, 1993.
67. Hong CZ: Lidocaine injection versus dry needing to myofascial trigger point: the importance of the local twitch response. Am J Phys Med Rehabil 73:256–263, 1994.
68. Hong CZ: Considerations and recommendations regarding myofascial trigger point injection. J Musculoske Pain 2(1):29–59, 1994.
69. Hong CZ: Persistence of local twitch response with loss of conduction to and from the spinal cord. Arch Phys Med Rehabil 75.12–16, 1994.
70. Hong CZ; Personal Communication, 1998.
71. Hong CZ, Chen YN, Twehous D, et al.: Pressure threshold for referred pain by compression on the trigger point and adjacent areas. J Musculoske Pain 4(3):61–79, 1996.
72. Hong CZ, Hsueh TC: Difference in pain relief after trigger point injections in myo fascial pain patients with and without fibromyalgia. Arch Phys Med Rehabil 77(11):1161–1166, 1996.
73. Hong CZ, Simons DG: Response to treatment for pectoralis minor myofascial pain syndrome after whiplash. J Musculoske Pain 1(1):89—131, 1993.
74. Hong CZ, Torigoe Y: Electrophysiological characteristics of localized twitch responses in responsive taut bands of rabbit skeletal muscle. J Musculoske Pain 2(2):17–43, 1994.
75. Hong CZ, Torigoe Y, Yu J: The localized twitch responses in responsive taut bands of rabbit skeletal muscle fibers are related to the reflexes at spinal cord level. J Musculoske Pain 3(1):15–34, 1995.
76. Hubbard D: Personal Communication, 1994.
77. Irwin Y, Wagenvoord J: Shiatzu. J. B. Lippincott, Philadelphia, 1976.
78. Jackson R: The Cervical Syndrome. Ed. 4. Charles C. Thomas, Springfield, III., 1977 (pp. 310, 311).
79. Jacobs AW, Falls WM: Anatomy, Chapter 3. In: Foundations for Osteopathic Medicine. Edited by Ward RC. Williams & Wilkins, Baltimore, 1997, pp. 27–43 (see p. 35).
80. Jaeger B: Differential diagnosis and management of craniofacial pain. Chapter II. In: Endodontics. Ed. 4. Edited by Ingle JI, Bakland LK. Williams & Wilkins, Baltimore, 1994 (pp. 550–607).
81. Jaeger B, Reeves JL: Quantification of changes in myofascial trigger point sensitivity with the pressure algometer following passive stretch. Pain 27:203–210, 1986.
82. Jaeger B, Skootsky SA: Double blind, controlled study of different myofascial trigger point injection techniques [Abstract). Pain 4(Suppl):S292, 1987.
83. Janssens LA; Trigger points in 48 dogs with myofascial pain syndromes. Vet Surg 20:274–278, 1991.
84. Janssens LA: Trigger point therapy. Pmbl Vet Med 4:117–124, 1992.
85. Jones LH: Strain and Counterstrain. The American Academy of Osteopathy, Colorado Springs, 1981.
86. Kahn J; Electrical modalities in the treatment of myofascial conditions. Chapter 15. In: Myofascial Pain and Fibromyalgia. Edited by Rachlin ES. Mosby, St. Louis, 1994, pp. 473–485.
87. Kahn J; Phonophoresis technique questioned. Physical Therapy 76(12):1348–1349, 1996. (Letter)
88. Kamen LB, Miller LT; Complications of trigger point steroid injections and therapeutic ultrasound. Arch Phys Med Rehabil 69:778,1988. (Abstract)
89. Kelly M: New light on the painful shoulder. Med J Aust 1:488–493, 1942 (Case 2, p. 489).
90. Knott M, Voss DE: Proprioceptive Neuromuscular Facilitation. Ed. 2. Harper & Row, New York, 1968 (pp. 97–99).
91. Kraft GH, Johnson EW, LeBan MM. The fibrositis syndrome. Arch Phys Med Rehabil 49:155–162, 1968.
92. Kraus Н: The use of surface anesthesia in the treatment of painful motion. JAMA 16:2582–2583, 1941.
93. Kraus H: Clinical Treatment of Back and Neck Pain. McGraw-Hill, New York, 1970.
94. Kuchera WA, Kuchera ML: Osteopathic Principles in Practice. Second Edition Revised, Greyden Press, Columbus, 1994.
95. Kugelbeig E, Hagbarth KE: Spinal mechanism of the abdominal and erector spinae skin reflexes. Brain 81:290–304, 1958.
96. Laskin DM: Etiology of the pain-dysfunction syndrome. J Am Dent Assoc 79:147–153, 1969.
97. Lewis C, Gevirtz R, Hubbard D, et al.: Needle trigger point and surface frontal EMG measurements of psychophysiological responses in tension-type headache patients. Biofeedback Self Reg 19(3): 274–275, 1994.
98. Lewit K: The needle effect in the relief of myofascial pain. Pain 6:83–90, 1979.
99. Lewit K: Muskelfazilitations– und Inhibitionstechniken in der Manuellen Medizin. Teil II. Postisometrische Muskelrelaxation. Manuelle Med 19:12–22, 1981.
100. Lewit K: Postisometric relaxation in combination with other methods of muscular facilitation and inhibition. Manual Med 2101-104, 1986.
101. Lewit K: Manipulative Therapy in Rehabilitation of the Locomotor System. Ed. 2. Butterworth Heinemann, Oxford, 1991 (pp. 11, 81, 186).
102. Lewit K: Personal Communication, 1996.
103. Lewit K, Beiger M, Hoizmllller G, et al.: Breathing movements: the synkinesis of respiration with looking up and down. J Muscutoske Pain 5(4):57–69, 1997.
104. Liberson WT: Personal communication, 1979.
105. Lieber RL: Skeletal Muscle Structure and Function. Williams & Wilkins, Baltimore, 1992 (see pp. 42–45).
106. Lloyd DP: Integrative pattern of excitation and inhibition in two-neuron reflex arcs. J Neurophysiol 9:421–438, 1946.
107. Lundervold AJ: Electromyographic investigations during sedentary work, especially typewriting. BrJ Phys Med 14:32–36, 1951.
108. Lynn, Paulette: Personal Communication, 1993.
109. Macdonald AJ: Abnormally tender muscle regions and associated painful movements. Pain 8:197–205, 1980.
110. Magnusson SP, Simonsen EB, Aagaard P, et al.: Mechanical and physiological responses to stretching with and without preisometric contraction in human skeletal muscle. Arch Phys Med Rehabil 77:373–378, 1996.
111. Maigne R: Low back pain of thoracolumbar origin. Arch Phys Med Rehabil 61:389–395, 1980.
112. Maloney, M: Personal Communication, 1996.
113. Maigoles MS: Letter to the editor. Pain 8:115–117, 1980.
114. McKeag PW: Fibrositis and panniculitis. Br J Phys Med 8:107–109, 1933.
115. McLaughlin CW Jr: Procaine infiltration in treatment of acute sprains. Milit Surg 97:457–460, 1945.
116. McNulty WH, Gevirtz RN, Hubbard DR, et al.: Needle electromyographic evaluation of trigger point response to a psychological stressor. Psychophysiology 31(3):313–316, 1994.
117. Melzack R: The McGill pain questionnaire: major properties and scoring methods. Pain 1:277–299, 1975.
118. Mennell JM: Joint Pain: Diagnosis and Treatment Using Manipulative Techniques. Little, Brown and Company, Boston, 1964 (see pp. 3–5).
119. Mennell J: Spray-stretch for relief of pain from muscle spasm and myofascial trigger points. J Am Podiatry Assoc 66:873–876, 1976.
120. Mense S: Referral of muscle pain: new aspects. Am Pain Soc J 3:1–9, 1994.
121. Mense S, Simons DG: Muscle Pain. Williams & Wilkins, Baltimore. In Press.
122. Modell W, Travell J, et al.: Treatment of painful disorders of skeletal muscle. NY State J Med 48:2050–2059, 1948.
123. Modell W, Travell J, Kraus H, et al.: Relief of pain by ethyl chloride spray. NY State J Med 52:1550–1558, 1952.
124. Moldofsky H: The contribution of sleep-wake physiology to fibromyalgia, Chapter 13. In: Myofascial Pain and Fibromyalgia, Advances in Pain Research and Therapy, Vol. 17. Edited by Fricton JR, Awad EA. Raven Press, New York, 1990 (pp. 227–240).
125. Moldofsky H, Scarisback P, England R, et al.: Musculoskeletal symptoms and non-REM sleep disturbance in patients with «fibrositis syndrome» and healthy subjects. Psychosom Med 37:341–351, 1975.
126. Morgan GJ Jr: Panniculitis and erythema nodosum, Chapter 75. In: Textbook of Rheumatology. Edited by Kelley WN, Harris ED, Ruddy S, et al., Vol. 2. W. B. Saunders, Philadelphia, 1981 (pp. 1203–1207).
127. Nagler JH: Injection treatment of sprains. Milit Surg 96:528–529, 1945.
128. Nielsen AJ: Personal communication, 1981.
129. Novich MM: Physical therapy in treatment of athletic injuries. Tex State J Med 61:672–674, 1965.
130. Ottaviani LB, Childers MK: Localization of neuromuscular junctions through needle electromyography. Arch Phys Med Rehabil 76:1045, 1995. (Abstr)
131. Patton IJ, Williamson JA: Fibrositis as a factor in the differential diagnosis of visceral pain. Can Med Assoc J 58:162–166, 1948.
132. Pizzolato P, Mannheimer W: Histopathologic Effects of Local Anesthetic Drugs and Related Substances. Charles С Thomas, Springfield, IU., 1961 (pp. 40, 41, 60, 71).
133. Prudden B: Pain Erasure: The Bonnie Prudden Way. M. Evans & Co., New York, 1980 (PP. 18, 19).
134. Rachlin ES: Trigger point management. Chapter 9. In: Myofascial Pain and Fibromyalgia. Edited by Rachlin ES. Mosby, St. Louis, 1994 (pp. 173–195).
135. Rasch PJ, Burke RK: Kinesiology and Applied Anatomy. Ed. 6. Lea & Febiger, Philadelphia, 1978 (pp. 46, 47).
136. Reitinger A, Radner H, Tilscher H, et al.: Morphologische Untersuchung an Triggerpunkten [Morphologic study of trigger points]. Manuelle Medizin 34:256–262, 1996.
137. Rinzler SH, Stein I, Bakst H, et al.: Blocking effect of ethyl chloride on cardiac pain induced by ergonovine. Proc Soc Exp Biol Med 85:329–333, 1954.
138. Rinzler SH, Travell J: Therapy directed at the somatic component of cardiac pain. Am Heart J 35:248–268, 1948 (p. 250).
139. Ritchie JM, Ritchie BR: Local anesthetics: effect of pH on activity. Science 162:1394–1395, 1968.
140. Santiesteban AJ: Physical agents and musculoskeletal pain, Chapter 9. In: Orthopaedic and Sports Physical Therapy, Vol 2. Edited by Gould JA III, Davies GJ. CV Mosby, St. Louis, 1985:199–211.
141. Shea MJ, Keyworth D: Myofascial release: blending the somatic and orthopedic models. Clin Bull Myofascial Ther 2(1):65–75, 1997.
142. Simons DG: Muscle pain syndromes – parts I and II. Am J Phys Med 54:289–311, 1975, and 55:15–42, 1976.
143. Simons DG: Electrogenic nature of palpable bands and «Jump Sign» associated with myofascial trigger points. In: Advances in Pain Research and Therapy. Edited by Bonica JJ, Albe-Fessard D. Raven Press, New York, 1976 (pp. 913–918)
144. Simons DG: Referred phenomena of myofascial trigger points. Chap. 28. In: New Trends in Referred Pain and Hyperalgesia, No. 27 in the series Pain Research and Clinical Management. Edited by Vecchiet L, Albe-Fessard D, Lindblom U, et al. Elsevier Science Publishers, Amsterdam, 1993:341–357.
145. Simons DG: Neurophysiological basis of pain caused by trigger points. Am Pain Soc J 117-19, 1994.
146. Simons DG: Book Review of: Muscles. Masses and Motion. The Physiology of Normality, Hypotonicity, Spasticity and Rigidity, by E. G. Walsh. J Musculoske Pain 2(4):153–154, 1994.
147. Simons DG: Triggerpunkte und Myogelose [Trigger points and myogelosis]. Manuelle Medizin 35(6): 190–294, 1997.
148. Simons DG: Myofascial trigger points: the critical experiment. J Musculoske Pain 5(4):113–118, 1997.
149. Simons DG, Dexter JR: Comparison of local twitch responses elicited by palpation and needling of myofascial trigger points. J Musculoske Pain 3(1):49–61, 1995.
150. Simons DG, Hong CZ: Comment to Dr. Baldry’s dry needling technique. J Musculoske Pain 3(4):81–85, 1995.
151. Simons DG, Hong CZ, Simons LS: Nature of myofascial trigger points, active loci [Abstract]. J Musculoske Pain 3(Suppl 1):62, 1995.
152. Simons DG, Mense S: Understanding and measurement of muscle tone related to clinical muscle pain. Pain 75:1—17, 1998.
153. Simons DG, Stolov WC: Microscopic features and transient contraction of palpable bands in canine muscle. Am J Phys Med Rehabil 55:65–88, 1976.
154. Singh P, Maibach HI: Iontophoresis in drug delivery: basic principles and applications. Crit Rev Ther Drug Carrier Sys 11(2–3):161–213, 1994.
155. Sola AE, Kuitert JH: Myofascial trigger point pain in the neck and shoulder girdle. Northwest Med 54:980–984, 1955.
156. Stern S, Keren A: Extreme sinus bradycardia following routine venipuncture. JAMA 239:403–404, 1978.
157. Stembach RA: Pain Patients. Academic Press, N. Y., 1974 (pp. 5-11).
158. Tavernor D: Alleviation of postherpetic neuralgia. Lancet 2:671–673, 1960.
159. Telling WH: The clinical importance of fibrositis in general practice. Br Med J 1:689–692, 1935.
160. Tizes R: Cardiac arrest following routine venipuncture. JAMA 236: 1846–1847, 1976.
161. Travell J: Rapid relief of acute «stiff neck» by ethyl chloride spray. J Am Med Worn Assoc 4:89–95, 1949.
162. Travell J: Basis for the multiple uses of local block of somatic trigger areas (procaine infiltration and ethyl chloride spray). Miss Valley Med J 71:13–22, 1949.
163. Travell J: Early relief of chest pain by ethyl chloride spray in acute coronary thrombosis. Case Report. Circulation 3:120–124, 1951.
164. Travell J: Pain mechanisms in connective tissue. In: Connective Tissues, Transactions of the Second Conference, 1951. Edited by Ragan C. Josiah Macy, Jr. Foundation, New York, 1952 (pp. 90, 92–94, 105, 119, 121).
165. Travell J: Ethyl chlorides spray for painful muscle spasm. Arch Phys Med Rehabil 33:291–298, 1952.
166. Travell J: Referred pain from skeletal muscle: the pectoralis major syndrome of breast pain and soreness and the sternomastoid syndrome of headache and dizziness. NY State J Med 55:331–339, 1955 (pp. 332, 333).
167. Travell J: Factors affecting pain of injection. JAMA 158:368–371, 1955.
168. Travell J: Temporomandibular joint pain referred from muscles of the head and neck. J Prosthet Dent 10:745–763, 1960.
169. Travell J: Use and abuse of the muscles in housework. J Am Worn Med Assoc 18:159–162, 1963.
170. Travell J: Office Hours: Day and Night. The World Publishing Company, New York, 1968 (pp. 260, 262, 269, 270, 272, 273, 276, 283)
171. Travell J: Myofascial trigger points: clinical view. In: Advances in Pain Research and Therapy Vol 1. Edited by Bonica JJ, Albe-Fessard D, Raven Press, New York, 1976 (pp. 919–926).
172. Travell J: Identification of myofascial trigger point syndromes: a case of atypical facial neuralgia. Arch Phys Med Rehabil 62:100–106, 1981.
173. Travell JG: Chronic myofascial pain syndromes: mysteries of the history. Chapter 6. In: Advances in Pain Research and Therapy, Vol 17. Edited by Fricton JR, Awad E. Raven Press, Ltd., New York, 1990 (pp. 129–137).
174. Travell J, Koprowska I, Hirsch BB, et al.: Effect of ethyl chloride spray on thermal bums. J Pharmacol Exp Ther 101:36, 1951.
175. Travell J, Rinzler SH: Influence of ethyl chloride spray on deep pain and ischemic contraction of muscle. Fed Proc 8:339, 1949.
176. Travell J, Rinzler SH: The myofascial genesis of pain. Postgrad Med 11:425–434, 1952.
177. Vandam LD: Local anesthetics, 1. N Engl J Med 263:748–750, 1960.
178. Vecchiet L, Giamberardino MA, Dragani L, et al.: Latent myofascial trigger points: changes in muscular and subcutaneous pain thresholds at trigger point and target level. J Man Med 5:151–154, 1990.
179. Vecchiet L, Giamberardino MA, de Bigontina P, et al.: Comparative sensory evaluation of parietal tissues in painful and nonpainful areas in fibromyalgia and myofascial pain syndrome, Chapter 13. In: Proceedings of the 7th World Congress on Pain, Progress in Pain Research and Management, Vol. 2. Edited by Gebhart GF, Hammond DL, Jensen TS. IASP Press, Seattle, 1994, pp. 177–249.
180. Vogler P, Kraus H: Periostbehandlung, Kolonbehandlung: Zwei reflextherapeutische Methoden. George Thieme, Leipzig, 1975 (pp. 52–69).
181. Voss DE, Ionta MK, Myers BJ: Proprioceptive Neuromuscular Facilitation. Ed. 3. Harper & Row, Philadelphia, 1985.
182. Voss H: Tabelle der Muskelwichte des Marines, berechnet und zusammengestellt nach der Untersuchungen von W. Thiele (1884). AnatAnz 103:356–360, 1956.
183. Walpin LA: Bedroom posture: the critical role of a unique pillow in relieving upper spine and shoulder girdle pain. Arch Phys Med Rehabil 58:507, 1977.
184. Walsh EG: Muscles, Masses & Motion. The Physiology of Normality, Hypotonicity, Spasticity & Rigidity. MacKeith Press, Distributed by Cambridge University Press, 1992.
185. Weber EF: Ober die Langenverhaltnisse der Fleischfasem der Muskeln in Allgemeinen. Berichte ober die Verhandlungen der Koniglich Sachsischen Gesellschaft der Wissenschaften zu Leipzig 3:63–86, 1851.
186. Weeks VD, Travell J: Postural vertigo due to trigger areas in the sternocleidomastoid muscle. J Pediatr 47:315–327, 1955.
187. Weeks VD, Travell J: How to give painless injections. In A. M. A. Scientific Exhibits 1957. Grune & Stratton, New York, 1957 (pp. 318–322).
188. Whiteside J: Personal communication, 1995.
189. Willis WD Jr, Grossman RG: Medical Neurobiology. С. V. Mosby, St Louis, 1973 (p. 103).
190. Wilson TS: Manipulative treatment of subacute and chronic fibrositis. Br Med J 1:298–302, 1936.
191. Wu CM, Chen HH, Hong CZ: Inactivation of myofascial trigger points associated with lumbar radiculopathy: surgery versus physical therapy [Abstract). Arch Phys Med Rehabil 78:1040–1041, 1997.
192. Yagiela JA, Benoit PW, Buoncristiani RD, et al.: Comparison of myotoxic effects of lidocaine with epinephrine in rats and humans. Anesth Analg 60:471–480, 1981.
193. Yue SK: Initial experience in the use of boulinum toxin A for the treatment of myofascial related muscle dysfunctions [Abstract]. J Musculoske Pain 3(Suppl 1):22, 1995.
194. Zohn DA, Mennell JM: Musculoskeletal Pain: Diagnosis and Physical Treatment. Little, Brown and Company, Boston, 1976 (pp. 126–129, 190–193).
Suppliers
Cervipillo, TRU-EZE Mfg. Co., 27 635 Diaz, Temecula, CA 92 390
Dramanine, Searle Pharmaceuticals, Inc., Box 5110, Chicago, IL 60 680
Fluori-Methane and ethyl chloride spray, Gebauer Chemical Co., 94 100 St. Catherine Ave., Cleveland, OH 44 104
Hydrocollator Steam Pack, Chattanooga Corporation, 101 Memorial Drive, Chattanooga, TN 37 405
Medco-sooolator, Medco Products Co., Inc., P. O. Box 50 070, Tulsa, OK 74 150
Phenergau, Wyeth Laboratories, P. O. Box 8299, Philadelphia, PA 19 101
Petaba, Glenwood, Inc., 83 N. Summit St. Tenafly, NJ 07 670
Wal-Pil-O, RoLoke Co., Box 24DD3, West Los Angeles, CA 90 024







